Olympic Ophthalmics is a medical device company developing novel treatments for dry eye disease. The company’s focus is to develop devices to treat the signs and symptoms of Dry Eye Disease (DED). It works by stimulating the trigeminal parasympathetic pathway to activate the glands responsible for tear film production.Olympic Ophthalmics wasfounded in 2017 by Michael Gertner and is based in Issaquah, Washington.

Biotechnology

Health Care

Therapeutics

Olympic Ophthalmics

Olympic Ophthalmics' headquarters in Issaquah, WA, United States

Description

People (1)

Jobs (0)

Other offices